TY - JOUR
T1 - Survival of European children and young adults with cancer diagnosed 1995-2002
AU - Gatta, Gemma
AU - Zigon, Giulia
AU - Capocaccia, Riccardo
AU - Coebergh, Jan Willem
AU - Desandes, Emmanuel
AU - Kaatsch, Peter
AU - Pastore, Guido
AU - Peris-Bonet, Rafael
AU - Stiller, Charles A.
PY - 2009/4
Y1 - 2009/4
N2 - This study analyses survival in 40,392 children (age 0-14 years) and 30,187 adolescents/young adults (age 15-24 years) diagnosed with cancer between 1995 and 2002. The cases were from 83 European population-based cancer registries in 23 countries participating in EUROCARE-4. Five-year survival in countries and in regional groupings of countries was compared for all cancers combined and for major cancers. Survival for 15 rare cancers in children was also analysed. Five-year survival for all cancers combined was 81% in children and 87% in adolescents/young adults. Between-country survival differences narrowed for both children and adolescents/young adults. Relative risk of death reduced significantly, by 8% in children and by 13% in adolescents/young adults, from 1995-1999 to 2000-2002. Survival improved significantly over time for acute lymphoid leukaemia and primitive neuroectodermal tumours in children and for non-Hodgkin lymphoma in adolescents/young adults. Cancer survival in patients
AB - This study analyses survival in 40,392 children (age 0-14 years) and 30,187 adolescents/young adults (age 15-24 years) diagnosed with cancer between 1995 and 2002. The cases were from 83 European population-based cancer registries in 23 countries participating in EUROCARE-4. Five-year survival in countries and in regional groupings of countries was compared for all cancers combined and for major cancers. Survival for 15 rare cancers in children was also analysed. Five-year survival for all cancers combined was 81% in children and 87% in adolescents/young adults. Between-country survival differences narrowed for both children and adolescents/young adults. Relative risk of death reduced significantly, by 8% in children and by 13% in adolescents/young adults, from 1995-1999 to 2000-2002. Survival improved significantly over time for acute lymphoid leukaemia and primitive neuroectodermal tumours in children and for non-Hodgkin lymphoma in adolescents/young adults. Cancer survival in patients
KW - Adolescents
KW - Cancer survival
KW - Children
KW - Europe
KW - Population-based cancer registries
KW - Rare tumours
KW - Young adults
UR - http://www.scopus.com/inward/record.url?scp=62549126896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=62549126896&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2008.11.042
DO - 10.1016/j.ejca.2008.11.042
M3 - Article
C2 - 19231160
VL - 45
SP - 992
EP - 1005
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0959-8049
IS - 6
ER -